Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-48664844.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-75340109.88%
2024-60.08%
202324.18%
2022-4.46%
2021-70.66%
20201.55%
20192.27%
2018-113.09%
201765.91%
2016-65.53%